Results 71 to 80 of about 101,889 (202)

Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: the MOMENTUM Trial

, 2016
This study assessed the efficacy of maintenance treatment with multimatrix mesalazine following achievement of complete or partial remission after induction treatment with high-dose multimatrix mesalazine.
Inglis, Susi, Solomon, Dory, Rubin, David T., Dobru, Daniela, Márquez, Juan, D'Haens, Geert, Gabalec, Libor, Bradette, Marc, Magee, Elizabeth   +8 more
core   +1 more source

Efficacy and safety of medical therapies in microscopic colitis: a systematic review and network meta-analysis

Therapeutic Advances in Gastroenterology, 2023
Background: The mainstay of treatment for microscopic colitis (MC) is budesonide. However, the optimal formulation and dosage of budesonide to induce and maintain remission has not yet been clearly demonstrated.
Aditi Kumar, George Hiner, Matthew J. Brookes, Jonathan P. Segal   +3 more
doaj   +1 more source

Fish oil for induction of remission in ulcerative colitis

Cochrane Database of Systematic Reviews, 2006
Fish oil supplements, which are rich in n-3 fatty acids, may reduce inflammation, decrease the need for anti-inflammatory drugs, and promote normal weight gain in people with ulcerative colitis.This review evaluates the efficacy of fish oil for induction of remission in ulcerative colitis using all available randomised controlled trials.The Cochrane ...
De Ley, Maartje, de Vos, Rien, Hommes, Daniel W, Stokkers, Pieter C   +3 more
openaire   +2 more sources

Effectiveness of tacrolimus therapy in refractory ulcerative colitis compared to infliximab with propensity score matching

Scientific Reports
There is insufficient evidence comparing the outcomes of tacrolimus-based remission induction therapy with infliximab in refractory ulcerative colitis (UC) and evidence regarding optimal strategies after tacrolimus-based remission induction therapy.
Takeo Yoshihara, Takahiro Amano, Shinichiro Shinzaki, Yuri Tsujii, Akiko Asakura, Taku Tashiro, Mizuki Tani, Yuriko Otake-Kasamoto, Takuya Yamada, Yuko Sakakibara, Naoto Osugi, Shuji Ishii, Satoshi Egawa, Manabu Araki, Yuki Arimoto, Masanori Nakahara, Yoko Murayama, Ichizo Kobayashi, Kazuo Kinoshita, Hiroyuki Ogawa, Satoshi Hiyama, Narihiro Shibukawa, Masato Komori, Yorihide Okuda, Takashi Kizu, Tetsuhisa Kitamura, Minoru Kato, Yoshiki Tsujii, Takahiro Inoue, Hideki Iijima, Yoshito Hayashi, Tetsuo Takehara   +31 more
doaj   +1 more source

Methotrexate for induction of remission in refractory Crohn's disease [PDF]

Cochrane Database of Systematic Reviews, 2014
Although corticosteroids are effective for induction of remission of Crohn's disease, many patients relapse when steroids are withdrawn or become steroid dependent. Furthermore, corticosteroids exhibit significant adverse effects. The success of methotrexate as a treatment for rheumatoid arthritis led to its evaluation in patients with refractory Crohn'
John W D, McDonald, Yongjun, Wang, David J, Tsoulis, John K, MacDonald, Brian G, Feagan   +4 more
openaire   +2 more sources

Posaconazole for the prophylaxis of invasive aspergillosis in acute myeloid leukemia: Is it still useful outside the clinical trial setting?

Therapeutic Advances in Hematology, 2020
Background: Posaconazole prophylaxis during remission induction chemotherapy not only decreases the incidence of invasive aspergillosis (IA) but also improves the overall survival rate among patients with acute myeloid leukemia (AML). However, it remains
Tsung-Chih Chen, Ren Ching Wang, Yu-Hui Lin, Kuang-Hsi Chang, Li-Ya Hung, Chieh-Lin Jerry Teng   +5 more
doaj   +1 more source

MESALAZINE PLACE IN THERAPY OF ULCERATIVE COLITIS

Медицинский совет, 2017
Preparations of 5-aminosalycil acid (Mesalazine) are used as the first-line therapy to induce remission if the UC activity is minimal and as the priority drugs for anti-recurrence therapy of patients with UC and are included in the Russian ...
I. G. Bakulin, M. I. Skalinskaya, E. V. Skazyvaeva   +2 more
doaj   +1 more source

Results of chemotherapy by UKCCSG protocol in children with acute lymphoblastic leukemia: Clinical characteristics and outcome [PDF]

Background: Acute lymphoblastic leukemia (ALL) represents a clonal expansion and arrest of normal lymphoid hematopoiesis. ALL remains the most common malignancy in children.
پدرام, محمد, فتحی, افشین, هیرادفر, امیر عطا ا...   +2 more
core  

High rate of drug-free remission after induction therapy with golimumab in early peripheral spondyloarthritis

, 2018
Objective & Methods: New treatment algorithms using tumor necrosis factor (TNF) blockers in early stages of spondyloarthritis (SpA) induce high rates of clinical remission or low disease activity.
Renson, Thomas, Filip Van den Bosch, Carron, Philippe, Dirk Elewaut, Thomas Renson, Colman, Roos, Elewaut, Dirk, Van den Bosch, Filip, Gaëlle Varkas, Roos Colman, Varkas, Gaëlle, Philippe Carron   +11 more
core   +1 more source

A Case of Acute Myelogenous Leukemia in Long-Term Remission After Severe Infection Following Only One Course of Chemotherapy

Case Reports in Hematology
Acute myelogenous leukemia (AML) is characterized by the uncontrolled growth of tumor cells in the bone marrow. Standard treatment includes induction remission therapy followed by several courses of consolidation chemotherapy.
Motoharu Shibusawa
doaj   +1 more source